News	Events
Publications	Companies
Clinical Trials

Tag Archives: siRNA

• Appointment of Chief Business Officer

  0 Replies
  

  October 05, 2011

  London, September 21, 2011 - Silence Therapeutics plc (AIM: SLN) (“Silence”, the “Group” or the “Company”), a leading global RNA interference (RNAi) therapeutics company, today announces the appointment of Tony Sedgwick PhD, FRCPath as Chief Business Officer with immediate effect. Dr Sedgwick will be based in Silence’s London office and lead... Contine Reading & Discuss→

• Silence Therapeutics signs siRNA delivery collaboration with top 10 pharma company

  0 Replies
  

  September 30, 2011

  -- Collaboration to investigate potential of DACC in intravenous delivery of siRNAs to the lung -- London, UK, September 27, 2011 –Silence Therapeutics plc (AIM: SLN) (“Silence”), a leading RNA interference (RNAi) therapeutics company, today announces that it has entered into an agreement with one of the world’s leading global... Contine Reading & Discuss→

• Appointment of Chief Executive Officer

  0 Replies
  

  London, September 20, 2011 – Silence Therapeutics plc (AIM: SLN) (“Silence”, the “Group” or the “Company”), a leading global RNA interference (RNAi) therapeutics company, today announces the appointment of Thomas Christély as Chief Executive Officer with immediate effect. He will be based at Silence’s facility in Berlin. Thomas Christély (aged... Contine Reading & Discuss→